The MBRA (Mini Bio-Reactor Array) is an advanced laboratory system that allows us to study the human gut microbiota – community of microorganisms living in the digestive tract, including bacteria and fungi – in a highly controlled and reproducible way. Often described as a “artificial gut in the lab” the MBRA system enables researchers to grow and monitor an individual’s gut microbiota outside the body. 

Unlike traditional approaches, which provide only single time-point snapshots of the gut microbiota, the MBRA system allows for continuous observation of how microbial communities change over time. Each reactor within the system can be independently controlled, allowing researchers to test multiple conditions simultaneously – such as different drugs, nutrients (i.e., fibre, polyphenols, tryptophan), or probiotics – while maintaining consistency across experiments.

Importantly, the MBRA system can also assess how different individuals’ gut microbiota respond uniquely to the same dietary or medical interventions. This helps researchers better understand inter-individual variability and supports the development of precision nutrition and personalised medicine approaches, where therapies can be tailored to the specific microbial characteristics of each person.

Together, this makes the MBRA system a powerful preclinical platform for understanding how diet and other interventions shape the gut microbiota and influence health. It can be used to rapidly test promising new gut microbiota-targeted therapies before they are studied in people. By identifying which interventions are most effective for different microbial profiles, researchers can better design human clinical trials aimed at discovering new personalized therapies to improve symptoms, strengthen gut health, and support long-term disease prevention and management.